Gilead Sciences, Inc. (GIS.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 02:51PM CEST. Market open.
| Previous Close | 61.00 |
| Open | 61.20 |
| Bid | 61.35 x 50000 |
| Ask | 61.40 x 50000 |
| Day's Range | 60.66 - 61.24 |
| 52 Week Range | 60.66 - 80.08 |
| Volume | |
| Avg. Volume | 493 |
| Market Cap | 76.296B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 14.53 |
| EPS (TTM) | 4.21 |
| Earnings Date | Apr 25, 2024 |
| Forward Dividend & Yield | 2.85 (4.67%) |
| Ex-Dividend Date | Mar 14, 2024 |
| 1y Target Est | N/A |
Investor's Business DailyGilead Gives Up Big Gains As Covid Drug Drives Its Beat — Again
Gilead stock pared its gains Friday after beating first-quarter sales forecasts on the back of its Covid treatment, Veklury.
ZacksGilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat
Gilead (GILD) reports narrower-than-expected loss in the first quarter. Its sales beat estimates on higher HIV, Oncology and Liver Disease sales.
- Thomson Reuters StreetEvents
Q1 2024 Gilead Sciences Inc Earnings Call
Q1 2024 Gilead Sciences Inc Earnings Call
© 2024 Yahoo. All rights reserved.